VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318 | -31.5% | 150 | 0.0% | 0.00% | – |
| Q2 2023 | $464 | -42.5% | 150 | 0.0% | 0.00% | – |
| Q1 2023 | $807 | -19.1% | 150 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $998 | -0.2% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,000 | -99.9% | 150 | 0.0% | 0.00% | – |
| Q2 2022 | $746,000 | +37200.0% | 150 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | -33.3% | 150 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $3,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |